Profil
Dana M.
Alexander is currently Chief Technical Officer at Obsidian Therapeutics, Inc. Former positions include Senior Director-Biologics at Genzyme Corp.
and Chief Operating Officer at Anika Therapeutics, Inc. from 2016 to 2018.
Education includes an MBA from Boston University and an undergraduate degree from Northeastern University.
Aktive Positionen von Dana Alexander
| Unternehmen | Position | Beginn |
|---|
Ehemalige bekannte Positionen von Dana Alexander
| Unternehmen | Position | Ende |
|---|---|---|
| ANIKA THERAPEUTICS, INC. | Geschäftsführer | 12.01.2018 |
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Corporate Officer/Principal | - |
Ausbildung von Dana Alexander
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Anika Therapeutics, Inc.
Anika Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and commercializes therapeutic products for tissue protection, healing and repair | Health Technology |
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Boston University
Boston University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Northeastern University
Northeastern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
















